ATE242252T1 - Verfahren zur herstellung von 2-isocephem- derivaten - Google Patents

Verfahren zur herstellung von 2-isocephem- derivaten

Info

Publication number
ATE242252T1
ATE242252T1 AT96905005T AT96905005T ATE242252T1 AT E242252 T1 ATE242252 T1 AT E242252T1 AT 96905005 T AT96905005 T AT 96905005T AT 96905005 T AT96905005 T AT 96905005T AT E242252 T1 ATE242252 T1 AT E242252T1
Authority
AT
Austria
Prior art keywords
producing
derivatives
isocephem
oxaisocephem
isocephem derivatives
Prior art date
Application number
AT96905005T
Other languages
English (en)
Inventor
Michio Sasaoka
Daisuke Suzuki
Delsoo Suh
Yoshihisa Tokumaru
Original Assignee
Otsuka Kagaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Kagaku Kk filed Critical Otsuka Kagaku Kk
Application granted granted Critical
Publication of ATE242252T1 publication Critical patent/ATE242252T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT96905005T 1995-03-10 1996-03-06 Verfahren zur herstellung von 2-isocephem- derivaten ATE242252T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7079491A JPH08245635A (ja) 1995-03-10 1995-03-10 ２−イソセフェム誘導体の製造法
PCT/JP1996/000538 WO1996028453A1 (en) 1995-03-10 1996-03-06 Processes for the production of 2-isocephem derivatives

Publications (1)

Publication Number Publication Date
ATE242252T1 true ATE242252T1 (de) 2003-06-15

Family

ID=13691380

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96905005T ATE242252T1 (de) 1995-03-10 1996-03-06 Verfahren zur herstellung von 2-isocephem- derivaten

Country Status (6)

Country Link
US (2) US5688942A (de)
EP (2) EP1201670A3 (de)
JP (1) JPH08245635A (de)
AT (1) ATE242252T1 (de)
DE (1) DE69628516T2 (de)
WO (1) WO1996028453A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3775820B2 (ja) * 1995-03-10 2006-05-17 大塚化学ホールディングス株式会社 ハロゲン化β−ラクタム化合物の製造法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687870T2 (de) * 1985-09-09 1993-08-19 Otsuka Pharma Co Ltd 2-oxa-isocephemverbindungen, sie enthaltende zusammensetzungen und verfahren zu deren herstellung.
JPS63211283A (ja) * 1987-02-27 1988-09-02 Otsuka Pharmaceut Co Ltd 抗菌剤
JP2525170B2 (ja) * 1987-03-09 1996-08-14 大塚製薬株式会社 ２―オキサイソセフェム誘導体の製造方法

Also Published As

Publication number Publication date
US6063918A (en) 2000-05-16
EP0759437B1 (de) 2003-06-04
DE69628516T2 (de) 2004-04-22
EP0759437A4 (de) 1997-06-11
DE69628516D1 (de) 2003-07-10
WO1996028453A1 (en) 1996-09-19
JPH08245635A (ja) 1996-09-24
EP0759437A1 (de) 1997-02-26
EP1201670A3 (de) 2002-05-08
EP1201670A2 (de) 2002-05-02
US5688942A (en) 1997-11-18

Similar Documents

Publication Publication Date Title
DE69328962D1 (de) Verfahren zur herstellng von cyano-methoxyiminomethylderivaten
ATE477227T1 (de) Verfahren zur herstellung eines trans-4-amino-1- cyclohexancarbonsäurederivats
ATE157647T1 (de) Verfahren zur herstellung von alpha- ketoamidderivaten
DE69502572D1 (de) Verfahren zur Herstellung von Geranylgeraniol
ATE107295T1 (de) Verfahren zur herstellung von 1,5-benzothiazepin- derivaten.
ATE256687T1 (de) Verbesserungen in der herstellung von beta-lactam
BG50389A3 (en) A process for the production of delta 1,4-3-keto c21-semiester sieroids
ATE114637T1 (de) Verfahren zur herstellung von antikonvulsanten cyclischen aminosäureverbindungen.
ATE154348T1 (de) Verfahren zur herstellung von 1,5-benzothiazepin- derivaten
DE69628516D1 (de) Verfahren zur herstellung von 2-isocephem-derivaten
ATE384067T1 (de) Verfahren zur herstellung von 3-cephemderivaten
ATE139989T1 (de) Verfahren zur herstellung von niedrigem alkyl-2- oxo-l-gulonat
DE69809888D1 (de) Verfahren zur Herstellung von alpha-Aminoketonen
ATE414070T1 (de) Verfahren zur herstellung von optisch aktiven 2,4-dihydrobenzofuranverbindungen
EP1247807A4 (de) Verfahren zur herstellung von tetrahydropyranyl-4-sulfonat und eines 4-aminotetrahydropyranderivates
IT1197800B (it) Processo per la sintesi di acidi carbossilici
ATE131483T1 (de) Verfahren zur herstellung von penemen
ATE269863T1 (de) Verfahren zur herstellung von granisetron
ATE129231T1 (de) Verfahren zur herstellung von optisch aktiven norbornylaminderivaten.
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
ATE299498T1 (de) Verfahren zur herstellung von imidazolderivaten
ATE301637T1 (de) Verfahren zur herstellung von n-geschützten azetidin-2-carbonsäuren
ATE245140T1 (de) Derivate der aminoacryl-säure und ein verfahren zur herstellung derselben
DE69112297D1 (de) Verfahren zur herstellung eines isoxazolderivats.
ATE197949T1 (de) Verfahren zur herstellung von optisch aktivem (s)-(-)- und (r)-(+)- deoxyspergualin und zwischenprodukte dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties